Tests generally appear in the order most useful for common clinical situations
Click on number for test-specific information in the ARUP Laboratory Test Directory
Test Name and Number
Recommended Use
Limitations
Follow Up
Ehrlichia chaffeensis Antibodies, IgG & IgM by IFA 0051002
Method: Indirect Fluorescent Antibody
Use acute and convalescent samples to determine if infection is due to E. chaffeensis
Because low levels of IgM antibodies may occasionally persist for more than 12 months post-infection, a single IgM result should be interpreted with caution
Wright's Stain 0049176
Method: Stain/Microscopic
Confirm presence of Babesia
Additional Tests Available
Click on number for test-specific information in the ARUP Laboratory Test Directory
Test Name and Number
Comments
Ehrlichia chaffeensis Antibody, IgG by IFA 0051004
Method: Indirect Fluorescent Antibody
Ehrlichia chaffeensis Antibody, IgM by IFA 0051003
Method: Indirect Fluorescent Antibody
General References
Bakken JS, Dumler JS.Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.Ann N Y Acad Sci. 2006;1078:236-247. (Link to PubMed)
Dumler JS, Madigan JE, Pusterla N, Bakken JS.Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment.Clin Infect Dis. 2007;45 Suppl 1:S45-S51. (Link to PubMed)
Dumler JS.Anaplasma and Ehrlichia infection.Ann N Y Acad Sci. 2005;1063:361-373. (Link to PubMed)
Dumler JS.Molecular methods for ehrlichiosis and Lyme disease.Clin Lab Med. 2003;23(4):867-84, vi. (Link to PubMed)
Openshaw JJ, Swerdlow DL.Human ehrlichiosis: clinical and ecological challenges.South Med J. 2007;100(8):769-770. (Link to PubMed)
Stone JH, Dierberg K, Aram G, Dumler JS.Human monocytic ehrlichiosis.JAMA. 2004;292(18):2263-2270. (Link to PubMed)
Reviewed by
Litwin, Christine, M.D. Medical Director, Immunology at ARUP Laboratories; Professor, Clinical Pathology, University of Utah
Comprehensive Review: July 2008
Last Update: July 2008